Literature DB >> 25703927

Serum periostin levels correlate with airway hyper-responsiveness to methacholine and mannitol in children with asthma.

J-S Song1, J-S You1, S-I Jeong1, S Yang1, I-T Hwang1, Y-G Im2, H-S Baek1, H-Y Kim3, D-I Suh4, H-B Lee5, K Izuhara6.   

Abstract

BACKGROUND: Periostin is a matricellular protein, and its synthesis in airway epithelial cells and lung fibroblasts is induced by interleukin (IL)-4 and IL-13. The significance of periostin as a biomarker of TH 2-induced airway inflammation, and (importantly) as a measure of the response to TH 2-targeted therapy, has recently been emphasized. We explored the relationship between periostin and airway hyperresponsiveness (AHR) in asthmatic children.
METHODS: The study included 83 children aged 6-15 years in an asthmatic group (n = 54) and healthy controls (n = 29). We measured the periostin levels in serum and performed methacholine and mannitol provocation challenges. The responses to mannitol were expressed as the provocative dose causing a 15% fall in the FEV1 (the PD15 dose).
RESULTS: Of the 54 subjects with asthma, all had positive methacholine bronchial provocation test (BPT) results and 38 had positive mannitol BPT results. Children with asthma had significantly higher periostin levels than controls [76.0 (65.0-91.8) vs 71.0 (57.5-80.0) ng/mL; P = 0.017]. Periostin levels were significantly correlated with both the methacholine PC20 and mannitol PD15 values.
CONCLUSION: Serum levels of periostin, a new biomarker induced by IL-13, were higher in asthmatic children, and were associated with AHR to methacholine and mannitol.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  airway hyperresponsiveness; asthma; children; periostin

Mesh:

Substances:

Year:  2015        PMID: 25703927     DOI: 10.1111/all.12599

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  20 in total

1.  Early Elevation of Plasma Periostin Is Associated with Chronic Ventilator-Dependent Bronchopulmonary Dysplasia.

Authors:  Shawn K Ahlfeld; Stephanie D Davis; Katherine J Kelley; Brenda B Poindexter
Journal:  Am J Respir Crit Care Med       Date:  2016-12-01       Impact factor: 21.405

Review 2.  Biomarkers in Severe Asthma.

Authors:  Xiao Chloe Wan; Prescott G Woodruff
Journal:  Immunol Allergy Clin North Am       Date:  2016-08       Impact factor: 3.479

3.  Relationships among aeroallergen sensitization, peripheral blood eosinophils, and periostin in pediatric asthma development.

Authors:  Halie M Anderson; Robert F Lemanske; Joseph R Arron; Cecile T J Holweg; Victoria Rajamanickam; Ronald E Gangnon; James E Gern; Daniel J Jackson
Journal:  J Allergy Clin Immunol       Date:  2016-07-05       Impact factor: 10.793

4.  Integrative Analysis Reveals a miRNA-mRNA Regulatory Network and Potential Causative Agents in the Asthmatic Airway Epithelium.

Authors:  Jintao Zhang; Zihan Wang; Dong Zhang; Yun Pan; Xiaofei Liu; Xinrui Qiao; Wenjing Cui; Liang Dong
Journal:  J Asthma Allergy       Date:  2021-10-30

5.  Serum Periostin Predicts Wheezing Exacerbation: A Prospective Study in Preschool Children with Recurrent Wheezing.

Authors:  Pailin Yooma; Wiparat Manuyakorn; Adithep Sawatchai; Wanlapa Jotikasthira; Potjanee Kiewngam; Watcharoot Kanchongkittiphon
Journal:  Int Arch Allergy Immunol       Date:  2021-09-17       Impact factor: 2.749

6.  Serum Periostin Level in Children with Asthma.

Authors:  Ketan Kumar; Meenu Singh; Joseph L Mathew; Pankaj C Vaidya; Savita Verma Attri
Journal:  Indian J Pediatr       Date:  2022-07-15       Impact factor: 5.319

7.  Serum periostin among infants with severe bronchiolitis and risk of developing asthma: A prospective multicenter cohort study.

Authors:  Makiko Nanishi; Michimasa Fujiogi; Robert J Freishtat; Claire E Hoptay; Cindy S Bauer; Michelle D Stevenson; Carlos A Camargo; Kohei Hasegawa
Journal:  Allergy       Date:  2022-01-17       Impact factor: 14.710

Review 8.  Predicting Severe Asthma Exacerbations in Children.

Authors:  Sandeep Puranik; Erick Forno; Andrew Bush; Juan C Celedón
Journal:  Am J Respir Crit Care Med       Date:  2017-04-01       Impact factor: 21.405

Review 9.  Using Periostin as a Biomarker in the Treatment of Asthma.

Authors:  Kenji Izuhara; Shoichiro Ohta; Junya Ono
Journal:  Allergy Asthma Immunol Res       Date:  2016-11       Impact factor: 5.764

10.  Higher serum levels of periostin and the risk of exacerbations in moderate asthmatics.

Authors:  N Scichilone; C Crimi; A Benfante; S Battaglia; M Iemmolo; M Spatafora; N Crimi
Journal:  Asthma Res Pract       Date:  2016-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.